Lifeward (NASDAQ:LFWD) Upgraded to “Hold” at Zacks Research

Lifeward (NASDAQ:LFWD) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued on Monday,Zacks.com reports.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Lifeward in a report on Friday, July 17th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $10.00.

Lifeward Stock Down 1.7%

NASDAQ LFWD opened at $6.99 on Monday. The stock’s 50-day moving average price is $7.39 and its 200-day moving average price is $7.05. The company has a quick ratio of 1.82, a current ratio of 2.40 and a debt-to-equity ratio of 1.16. Lifeward has a 52 week low of $4.14 and a 52 week high of $10.56. The company has a market capitalization of $19.63 million, a P/E ratio of -0.36 and a beta of 0.37.

Lifeward (NASDAQ:LFWD) last posted its quarterly earnings data on Friday, May 15th. The company reported ($6.70) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.18) by ($5.52). The company had revenue of $3.92 million for the quarter, compared to analysts’ expectations of $5.78 million. Lifeward had a negative net margin of 123.66% and a negative return on equity of 243.14%. On average, equities research analysts predict that Lifeward will post -4.27 earnings per share for the current year.

Hedge Funds Weigh In On Lifeward

Large investors have recently made changes to their positions in the business. Virtu Financial LLC boosted its stake in shares of Lifeward by 158.0% in the fourth quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock worth $35,000 after acquiring an additional 37,037 shares during the period. Jane Street Group LLC raised its stake in Lifeward by 77.3% during the 4th quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock valued at $40,000 after purchasing an additional 29,927 shares during the period. HRT Financial LP raised its stake in Lifeward by 149.7% during the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock valued at $28,000 after purchasing an additional 29,423 shares during the period. Finally, Citadel Advisors LLC lifted its holdings in Lifeward by 1,271.8% in the 3rd quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock worth $152,000 after purchasing an additional 198,406 shares in the last quarter. 26.76% of the stock is currently owned by hedge funds and other institutional investors.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.